Médecins pour Immunothérapie à l'étranger — Page 3

Le Professeur Associé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'Hôpital Universitaire Istinye Liv.

• Plus d'une décennie d'expérience en oncologie
• A travaillé à la Clinique d'Oncologie d'Ankara et à l'Hôpital Régional de Formation et de Recherche d'Erzurum
• Promu Professeur Associé en 2016
• A étudié la médecine à l'Université Selcuk

Professeur Associé d'Oncologie Médicale à l'Hôpital Liv de l'Université İstinye Topkapı – spécialisé dans l'immunothérapie pour le traitement du cancer.

• Plus de 10 ans d'expérience en oncologie médicale
• Membre de l'American Society of Clinical Oncology (ASCO)
• A publié plusieurs articles évalués par des pairs sur les résultats des traitements oncologiques
• Se concentre sur l'immunothérapie pour divers types de cancer

Le Prof. Assoc. Nail Paksoy est spécialisé en immunothérapie à l'Hôpital Medipol Bahçelievler, avec une solide expérience en oncologie médicale et en allergologie-immunologie.

• Certifié par l'ESMO en oncologie médicale
• A participé à 8 essais cliniques internationaux pour l'immunothérapie
• A publié de multiples études sur les résultats du traitement du cancer
• Formation de bourse (Fellowship) à l'Institut d'oncologie de l'Université d'Istanbul

Le Dr Salman est spécialisé en immunothérapie pour divers cancers, intégrant des thérapies ciblées et des vaccins contre le cancer. Il a été formé dans des institutions prestigieuses comme le Memorial Sloan Kettering Cancer Center.

• Professeur agrégé à l'Université Katip Çelebi avec plus de 7 ans d'expérience en oncologie médicale
• Visiteur académique au Moffitt Cancer Center en Floride, États-Unis
• Membre du conseil d'administration de la Société Turque d'Oncologie Médicale et de la Société Européenne d'Oncologie Médicale
• Utilise un profilage génomique complet pour des plans de traitement personnalisés
• Actif dans la recherche clinique et les thérapies médicales expérimentales

Le Dr Alemdar est spécialisé en oncologie médicale et a suivi une formation approfondie à l'Université Akdeniz, un leader de la recherche sur le cancer.

• Certifié en oncologie médicale depuis 2018
• Exerce au Medical Park Antalya Hospital Complex
• Plus de 15 ans d'expérience en médecine interne et en oncologie
• Formé à l'Université Akdeniz – le premier centre de recherche sur le cancer en Turquie

Le Dr Ozden est spécialisé en oncologie médicale et possède plus de 20 ans d'expérience en médecine interne et en oncologie.

• A complété sa surspécialité en oncologie médicale à la Faculté de Médecine de l'Université de Kocaeli
• A exercé la médecine interne dans plusieurs hôpitaux en Turquie
• Est diplômé de la Faculté de Médecine Cerrahpaşa de l'Université d'Istanbul

Le Professeur Associé Atakan Topcu est spécialisé en immunothérapie et en thérapies ciblées pour les tumeurs solides à l'Hôpital de District Medipol Acibadem.

• A publié plus de 50 articles scientifiques en oncologie
• Membre de la Société Européenne d'Oncologie Médicale (ESMO)
• Expert en oncologie gériatrique et en malnutrition liée au cancer
• Titulaire d'un fellowship en oncologie médicale, formé à l'Université Bezmialem Vakıf

Professeur d'Oncologie Médicale avec plus de 20 ans d'expérience, spécialisé dans les traitements avancés contre le cancer à l'Hôpital Liv Topkapı de l'Université İstinye.

• Formation de spécialisation (Fellowship) en Oncologie Médicale à l'Université de Trakya
• Professeur agrégé puis Professeur à la Faculté de Médecine de l'Université de Trakya
• Membre de l'Association Turque d'Oncologie Médicale

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.